List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 36 studies with search of: Rifaximin
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Not yet recruiting Rifaximin Treatment of Papulopustular Rosacea
Condition: Rosacea
Interventions: Drug: Rifaximin (XIFAXAN);   Drug: Placebo
2 Unknown † Study of Rifaximin in Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Interventions: Drug: Rifaximin;   Drug: rifaximin
3 Recruiting Induction of Clinical Response Using Rifaximin in Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Placebo Comparator;   Drug: Rifaximin
4 Completed Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Rifaximin;   Drug: Placebo
5 Recruiting Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
Condition: Rectal Cancer
Interventions: Drug: Rifaximin;   Drug: Placebo
6 Recruiting Rifaximin in Fatty Liver Disease
Conditions: Nonalcoholic Fatty Liver Disease;   NAFLD;   Nonalcoholic Steatohepatitis
Intervention: Drug: Rifaximin
7 Recruiting Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)
Conditions: Malignancy;   Bone Marrow Transplantation
Intervention: Drug: Rifaximin
8 Completed Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Rifaximin-EIR
9 Completed Rifaximin 3 Times/Day for Non-constipation IBS
Condition: Non-constipation Irritable Bowel Syndrome
Interventions: Drug: Rifaximin;   Drug: Placebo
10 Completed Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy Volunteers
Condition: Pharmacokinetic
Intervention: Drug: rifaximin
11 Recruiting Rifaximin as a Modulator of Microbial Translocation and Immune Activation
Condition: HIV-1 Infection
Intervention: Drug: Rifaximin
12 Unknown † RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin alone, Rifaximin combined with Lactulose
13 Active, not recruiting Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial
Condition: Hepatic Encephalopathy
Interventions: Drug: Rifaximin plus lactulose;   Drug: Lactulose
14 Unknown † Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin
Condition: Diarrhoea
Interventions: Drug: Rifaximin;   Drug: Lactose
15 Completed Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea
Condition: Diarrhea
Intervention: Drug: rifaximin
16 Completed Rifaximin TID for Non-constipation Irritable Bowel Syndrome (IBS)
Condition: Non-constipation Irritable Bowel Syndrome
Interventions: Drug: Rifaximin;   Drug: Placebo
17 Completed Trial of Rifaximin in the Treatment of Tropical Enteropathy
Condition: Tropical Enteropathy
Intervention: Drug: Rifaximin
18 Withdrawn Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea
Condition: Travelers' Diarrhea
Intervention: Drug: Rifaximin
19 Completed Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea
Condition: Travelers' Diarrhea
Intervention: Drug: Rifaximin and loperamide
20 Recruiting Rifaximin Versus Lactulose in Renal Failure
Conditions: Liver Cirrhosis;   Renal Failure
Interventions: Drug: Rifaximin;   Drug: Lactulose

Previous Page Studies Shown (1-20) Next Page (21-36)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services